Ensuring global availability of safe and effective vaccines.

Quad partners are working collaboratively to achieve expanded manufacturing of safe and effective COVID-19 vaccines at facilities in India, prioritizing increased capacity for vaccines authorized by Stringent Regulatory Authorities (SRA). Quad partners will address financing and logistical demands for production, procurement, and delivery of safe and effective vaccines.

The United States, through the DFC, will work with Biological E Ltd., to finance increased capacity to support Biological E’s effort to produce at least 1 billion doses of COVID-19 vaccines

Japan, through JICA, is in discussions to provide concessional yen loans for the Government of India to expand manufacturing for COVID-19 vaccines for export

Ensure expanded manufacturing will be e for global benefit, to be procured through key multilateral initiatives, such as COVAX, that provide life-saving vaccines for low-income countries, and by countries in need.

Quad partners will also cooperate to strengthen “last-mile” vaccination, in the Indo-Pacific.

This includes supporting countries with vaccine readiness and delivery, vaccine procurement, health workforce preparedness

Australia will contribute US$77 million for the provision of vaccines and “last-mile” delivery support with a focus on Southeast Asia full vaccine coverage to nine Pacific Island countries and Timor-Leste, and support procurement, prepare for vaccine delivery, and strengthen health systems in Southeast Asia.

Japan will assist vaccination programs of developing countries such as the purchase of vaccines and cold-chain support including through provision of grant aid of $41 million

The United States will leverage existing programs to further boost vaccination capability, drawing on at least $100 million in regional efforts focused on immunization. launch of a senior-level Quad Vaccine Experts Group, comprised of top scientists and officials from our governments

Design an implementation plan for the Quad COVID-19 vaccine effort;   
identify hurdles impeding vaccine administration in the region;   
work with financers and production facilities to monitor timely and sufficient capacity expansion, share governmental plans to support Indo-Pacific health security and COVID-19 response strengthen and support the life-saving work of international organizations, including the WHO, COVAX, Gavi, CEPI, UNICEF, the G7, ASEAN, and governments, and call on other countries to do the same.

*Make additional concrete recommendations before the end of the year.